Northwestern Mutual Wealth Management CO Novo Cure LTD Transaction History

Northwestern Mutual Wealth Management CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $1,589 - $2,213	128 New	128 $2,000
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $4,109 - $8,416	-102 Reduced 97.14%	3 $0
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $5,361 - $11,286	-95 Reduced 47.5%	105 $6,000
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $9,450 - $12,450	139 Added 227.87%	200 $15,000
Q2 2022 Aug 04, 2022	BUY	$56.6 - $89.9 $3,396 - $5,394	60 Added 6000.0%	61 $4,000
Q1 2022 May 09, 2022	SELL	$60.15 - $84.52 $1,142 - $1,605	-19 Reduced 95.0%	1 $0
Q4 2021 Feb 03, 2022	BUY	$75.08 - $121.99 $450 - $731	6 Added 42.86%	20 $2,000
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $15,218 - $25,486	-131 Reduced 90.34%	14 $2,000
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $18,908 - $32,709	145 New	145 $32,000
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $858 - $1,116	-15 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$57.05 - $95.75 $684 - $1,149	12 Added 400.0%	15 $1,000
Q4 2019 Feb 13, 2020	BUY	$68.3 - $93.8 $204 - $281	3 New	3 $0

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.